Business Context and Reporting Period
This Form 8-K Current Report, filed on January 17, 2025, by Medtronic plc (Ireland), discloses the appointment of a new Chief Financial Officer and compensation adjustments for the interim CFO. The report covers events announced on January 21, 2025, with the new CFO's effective date set for March 3, 2025.
Key Financial Metrics
This filing does not contain operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on executive compensation and personnel changes.
Material Changes
The primary material change is the leadership transition in the finance function:
- Appointment: Thierry Pieton is appointed as Executive Vice President and Chief Financial Officer, effective March 3, 2025.
- Interim Role: Gary Corona continues as Interim CFO until the effective date of the new appointment.
Guidance, Outlook, and Compensation Details
The filing details the compensatory arrangements for the new CFO and the interim CFO:
Thierry Pieton (New CFO)
- Base Salary: $850,000 annually.
- Short-Term Incentive: Target payout of 110% of base salary ($935,000) for FY2025, prorated.
- Long-Term Incentive (FY2025): Aggregate target value of $2 million, consisting of:
- $1 million in Performance Share Units (PSUs).
- $600,000 in stock options (vesting 25% annually).
- $400,000 in Restricted Stock Units (RSUs) (vesting 100% in year 3).
- Sign-on Cash Bonus: $3 million total to compensate for foregone compensation, payable in three equal installments over 18 months.
- Sign-on Equity: One-time RSU award valued at $2.5 million to compensate for unvested equity at prior employer, vesting in 1/3 increments annually.
- Benefits: Includes an annual $24,000 allowance for automobile and personal expenses, and an 8% contribution to a non-qualified deferred compensation plan.
Gary Corona (Interim CFO)
- One-Time Grant: $1 million in RSUs granted on January 21, 2025, vesting 100% on the one-year anniversary.
Investor Verification Checklist
- Verify the exact vesting schedules and performance metrics for the $1 million PSU award granted to Thierry Pieton.
- Confirm the impact of the $3 million sign-on cash bonus and $2.5 million equity grant on the company's near-term cash flow and share dilution.
- Review the "Section 16 Officer severance plan" referenced in the filing to understand potential termination costs.
- Monitor the transition timeline to ensure continuity of financial reporting between the interim and permanent CFO.